NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27514.
Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill has participated in 14 clinical trials with 6 currently active.
Therapeutic areas: HIV-1 Infection, HIV Pre-exposure Prophylaxis, Pre-Exposure Prophylaxis of HIV Infection.
Sponsors: Gilead Sciences, Merck Sharp & Dohme LLC, Vertex Pharmaceuticals Incorporated.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Chapel Hill
Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill has 14 clinical trials on record, with 6 currently active. Their work covers HIV-1 Infection, HIV Pre-exposure Prophylaxis, Pre-Exposure Prophylaxis of HIV Infection.
NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.